Evidence map›Paper›PMID 16397296›Full record

ArticleNucleic acids research2006

Selection of primer-template sequences that bind human immunodeficiency virus reverse transcriptase with high affinity.

Jeffrey J DeStefano, Jason V Cristofaro

Abstract read
In one paragraph

Article in Nucleic acids research, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Cryo-EM structures of wild-type and E138K/M184I mutant HIV-1 RT/DNA complexed with inhibitors doravirine and rilpivirine.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Aptamers against pathogenic microorganisms.Critical reviews in microbiology · 2016
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Oligomeric nucleic acids as antivirals.Molecules (Basel, Switzerland) · 2011
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jeffrey J DeStefanoDepartment of Cell Biology and Molecular Genetics, University of Maryland, Building 231, College Park, MD 20742, USA. jdestefa@umd.edu
Jason V Cristofaro

Funding

MECHANISM OF RECOMBINATION BY HIV REVERSE TRANSCRIPTASER01GM051140 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI DESTEFANO, JEFFREY J · 2000 to 2011
$3.0M
MECHANISM OF RECOMBINATION BY HIV REVERSE TRANSCRIPTASER29GM051140 · NIGMS · UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS · PI DESTEFANO, JEFFREY J · 1994 to 1998
–
NIGMS NIH HHS GM051140NIGMS NIH HHS R01 GM051140NIGMS NIH HHS R29 GM051140
6 · The paper itself

Abstract

A SELEX (systematic evolution of ligands by exponential enrichment)-based approach was developed to determine whether HIV-RT showed preference for particular primer-template sequences. A 70 nt duplex DNA was designed with 20 nt fixed flanking sequences at the 3' and 5' ends and a randomized 30 nt internal sequence. The fixed sequence at the 5' end contained a BbsI site six bases removed from the randomized region. BbsI cuts downstream of its recognition site generating four base 5' overhangs with recessed 3' termini. Cleavage produced a 50 nt template and 46 nt primer with the 3' terminus within the randomized region. HIV-RT was incubated with this substrate and material that bound RT was isolated by gel-shift. The recovered material was treated to regenerate the BbsI site, amplified by PCR, cleaved with BbsI and selected with HIV-RT again. This was repeated for 12 rounds. Material from round 12 bound approximately 10-fold more tightly than starting material. All selected round 12 primer-templates had similar sequence configuration with a 6-8 base G run at the 3' primer terminus, similar to the HIV polypurine tract. Further modifications indicate that the Gs were necessary and sufficient for strong binding.

Indexed as

Aptamers, NucleotideBase SequenceBinding SitesGuanineHIV Reverse TranscriptaseRNASELEX Aptamer TechniqueTemplates, GeneticAptamers, NucleotideGuanineHIV Reverse TranscriptaseRNARNA primers

Identifiers

PMID16397296
PMCPMC1325207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.